David A. Spellman

Companies

• Akebia Therapeutics, Inc.Chief financial officer Jul 2, 2020 to May 18, 2023¹
• Mersana Therapeutics (United States)Chief financial officer Mar 14, 2018 to Jan 25, 2019²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAkebia Therapeutics, Inc. AKBA446,483 shares³$315.2K at $0.71May 16, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• May 16, 2023Sold 63,567 shares at $1.07 of Akebia Therapeutics, Inc.³
• Mar 1, 2023Sold 810 shares at $0.88 of Akebia Therapeutics, Inc.⁴
• Mar 1, 2023Sold 6,400 shares at $0.88 of Akebia Therapeutics, Inc.⁴
• Feb 27, 2023Sold 7,539 shares at $0.81 of Akebia Therapeutics, Inc.⁵
• Jan 31, 2023Granted 196,200 shares of Akebia Therapeutics, Inc.⁶
• Jun 8, 2022Granted 200,000 shares of Akebia Therapeutics, Inc.⁷
• Mar 1, 2022Sold 803 shares at $2.17 of Akebia Therapeutics, Inc.⁸
• Feb 28, 2022Granted 60,000 shares of Akebia Therapeutics, Inc.⁸
• Feb 28, 2022Sold 7,400 shares at $2.15 of Akebia Therapeutics, Inc.⁸